AMPULLA OF VATER CANCER
Clinical trials for AMPULLA OF VATER CANCER explained in plain language.
Never miss a new study
Get alerted when new AMPULLA OF VATER CANCER trials appear
Sign up with your email to follow new studies for AMPULLA OF VATER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can two targeted drugs boost chemo against a rare Bile-Duct cancer?
Disease control OngoingThis phase 2 trial is testing whether adding either ramucirumab (a blood-vessel blocker) or merestinib (a cell-signal blocker) to standard chemotherapy (cisplatin + gemcitabine) can help people with advanced or metastatic biliary tract cancer live longer without their disease wor…
Matched conditions: AMPULLA OF VATER CANCER
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New drug cocktail shows promise for tough bile duct cancer
Disease control OngoingThis phase 2 trial tests a combination of two drugs, lenvatinib and paclitaxel, in 51 adults with advanced biliary tract cancer that has worsened after standard gemcitabine treatment. The goal is to see if the combo can shrink tumors and slow the disease. Participants take lenvat…
Matched conditions: AMPULLA OF VATER CANCER
Phase: PHASE2 • Sponsor: National Health Research Institutes, Taiwan • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC